Elephas is leading the way to change how clinicians treat cancer patients. The Elephas platform uses human Live Tumor Fragments (hLTF)TM and combines the latest advances in cancer biology, multimodal microscopy, and artificial intelligence to predict immunotherapy response. The Elephas platform empowers clinical decision making and accelerates drug development.